HOME >> BIOLOGY >> NEWS
X-rays may show way to better Alzheimer's drugs

Weizmann Institute scientists explain how a plant substance blocks a key brain enzyme involved in Alzheimer's disease

REHOVOT, Israel -- December 27, 1999 -- Weizmann Institute researchers have revealed the exact nature of the 3-D interaction between galanthamine, a natural substance extracted from the common snowdrop (Galanthus nivalis) and the brain enzyme acetylcholinesterase (AChE). Their findings, appearing in the December 17 issue of the Federation of European Biochemical Societies (FEBS Letters), may provide crucial information in designing a new family of Alzheimers drugs.

Alzheimer's disease is a severe degenerative disorder causing memory loss and other cognitive deficits in roughly 10 percent of the elderly. One of its pathological hallmarks is the deterioration of nerve cells releasing acetylcholine a neurotransmitter that helps ferry messages in the form of nerve impulses between brain cells. The acetylcholine shortage that ensues is compounded by the action of acetylcholinesterase (AChE), the enzyme which breaks down acetylcholine in the body at an astonishing rate of 20,000 molecules per second.

Blocking acetylcholine breakdown

While scientists have yet to understand the cause of the disease, several Alzheimers drugs already exist, including Aricept, HupA (huperzine A), and Cognex (tacrine). Their underlying approach is to attempt to restore acetylcholine levels by inhibiting AChE activity.

Using X-ray crystallography, Dr. Harry Greenblatt of the Weizmann Institutes Department of Structural Biology, has revealed that galanthamine acts in a similar manner, replenishing acetylcholine levels by binding to AChEs active site and shutting off its "cutting machinery." Greenblatt conducted the research together with Dr. Gitay Kryger, and Professors Joel Sussman, and Israel Silman, all of the Weizmann Institute, as well as Dr. Terry Lewis of Zeneca Agrochemicals, in England.

However, ac
'"/>

Contact: Jeffrey J Sussman
jeffrey@acwis.org
212-895-7951
American Committee for the Weizmann Institute of Science
26-Dec-1999


Page: 1 2 3 4

Related biology news :

1. Many physicians misperceive radiation risks to developing fetuses from X-rays and CT scans
2. Lycopene slows human prostate tumour growth in mice and combined with vitamin E is even better
3. Microbes eat their way to better concrete
4. Computer database being developed at Temple will allow for better inventory of chemicals
5. New and better drugs for tuberculosis goal of UH professor
6. Ants protect plants better when jacked up on nectar
7. The blind really do hear better
8. Microarrays, key genome expression trackers, work better when probes are sequence-verified
9. Researchers develop better understanding of immune response to viral infection
10. Crack babies do better when placed with non-family caregivers
11. A better way to copy DNA

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/1/2020)... ... April 30, 2020 , ... Flagship Biosciences , providers ... a biopharmaceutical and regulatory services advisor. The companies now deliver regulatory strategy and ... are taking a collaborative approach to empower more confident and informed regulatory decisions ...
(Date:4/30/2020)... (PRWEB) , ... April 28, 2020 , ... Pebble ... world’s biggest challenges in agriculture and aquaculture with the mission of improving global food ... the 2020 F&A Next ' Next Heroes in Food- and Ag-Tech ' virtual event, ...
(Date:4/28/2020)... (PRWEB) , ... April 27, 2020 , ... ... first-of-its-kind category-defining service was started by three teenagers with an idea to help ... the world during the time of great need and suffering, an outlet has ...
Breaking Biology News(10 mins):
(Date:4/18/2020)... ... April 17, 2020 , ... NeuroFlow has been ... program to support the expansion of its digital health platform enabling behavioral health ... rigorous merit-based review process, adds to NeuroFlow’s recent government awards . , ...
(Date:4/1/2020)... ... March 30, 2020 , ... Kinetic Vet, an ... an EPA-approved spray-on antimicrobial solution. As a first-of-its-kind technology within the animal health ... activity against microorganisms for up to 90 days. , In addition to reducing ...
(Date:4/1/2020)... LAKE CITY, and LA JOLLA, Calif. (PRWEB) , ... March 31, ... ... characterization tools, and La Jolla Institute for Immunology (LJI), announced today that they will ... days allowing CoVIC to move therapeutic candidates to the clinic as early as this ...
(Date:3/27/2020)... ... ... iFirst Medical Technologies, Inc., a leader in handheld diagnostic devices, announced today that ... grave danger to public health here in the U.S. and around the globe," said ... and on-the-spot results promise to slow the spread and save human lives." , iFirst ...
Breaking Biology Technology:
Cached News: